Copy
View this email in your browser
The Journey Newsletter (February 2026)
January was dedicated to charting the course for the OHDSI global community in 2026. Our first community call of the year underscored a number of opportunities for innovation and cross-functional collaboration. With landmark events like Phenotype Phebruary and the 2026 Europe Symposium coming soon, the stage is set for a transformative year. How will you contribute to the OHDSI mission in 2026? #JoinTheJourney
OHDSI Teams/Email Outage Update;
Feb. 3 Community Call Will Be Cancelled
As many of you have experienced, there were two instances in January when a significant portion of the community lost access to both our MS Teams environment and their OHDSI emails. While we continue to work with Microsoft on this issue, the process has taken longer than anticipated.

We recognize this has severely impacted our ability to collaborate. As such, we are going to postpone the Feb. 3 community call to focus on workgroup OKRs because we know many of you were not able to have your latest meetings. 

Also, we have extended the deadline for both the plenary and tutorial proposals until Feb. 13. Details on these proposals, as well as the submission links, are available here on the symposium homepage.
Podcast: 2026 Pathways, Phenotype Phebruary
In the February 2026 On The Journey podcast, Patrick Ryan and Craig Sachson discuss potential pathways for the OHDSI community to innovate and collaborate in the coming year. They also look ahead to Phenotype Phebruary and the submission deadline for the 2026 Europe Symposium collaborator showcase. (If video does not appear, please click 'view this email in your browser.)
Community Updates
Where Have We Been?
• Chris Mecoli, Associate Professor of Medicine at the Johns Hopkins University, introduced a new network study last month: Comparative Risk of Infection in Rheumatic Disease Patients Initiating Immunosuppressive Therapy. If you are interested in participating in this study, please reach out to Chris at cmecoli1@jhmi.edu.
• Discover how the OMOP CDM powers global, large-scale health research in this new “bite-sized” video learning pathway, developed in collaboration with Prof. Daniel Prieto-Alhambra’s team at Oxford University. Designed for researchers and data holders, this course explores how a standardized infrastructure enables reproducible, federated analytics while ensuring regulatory compliance.

Where Are We Now?
• Feb. 6 is the submission deadline for the 2026 Europe Symposium, which will be held April 18-20 in Rotterdam. Learn more about the showcase and use this link to submit your abstract.
• The submission deadline for both plenary and tutorial proposals for the 2026 Global Symposium (Oct. 20-22, New Brunswick, N.J.) have been extended to Feb. 13. More information on both can be found on the event homepage.
• The #OHDSISocialShowcase is currently highlighting research from the 2025 Global Symposium. Please follow our various social channels, including LinkedInX/TwitterBluesky and Instagram, to learn more about the research happening in our community.

Where Are We Going?
Registration is open for the 2026 Europe Symposium, which will feature two days of tutorials and workshops April 18-19 and a one-day conference April 20. The tentative agenda is now available for the seventh annual event, which returns to Rotterdam, Netherlands, this year.
• Save the date! The 2026 Global Symposium takes place Oct. 20-22 at the Hyatt Regency Hotel in New Brunswick, N.J. Agenda information and collaborator showcase details will be shared when available.
• Registration is now open for the 2026 Summer School in Observational Health Data Science & Informatics, AI, and Real World Evidence, which will be held June 22-26 at the Columbia University Department of Biomedical Informatics. Now in its second-year, the Columbia OHDSI Summer School provides health professionals, researchers, and industry practitioners with an immersive, hands-on training to working with real-world health data and generating real-world evidence (RWE).
Where Can OHDSI Go Together in 2026?
Patrick Ryan explored possible ways our community can move together during the initial community call of 2026. He discussed (among others) the potential of running a network study across the OHDSI Evidence Network for one drug of shared interest, applying best practices that are implemented using OHDSI HADES packages (including comparative cohort and SCCS designs), and sharing all results that pass objective diagnostics.

This talk highlights some of the late reflections of 2025, recent studies that inform potential directions, and plenty more.
Phenotype Phebrary Returns, Focuses on Testing an AI-Assisted Workflow

The OHDSI community is launching the fifth edition of Phenotype Phebruary, a month-long global initiative dedicated to advancing the way we build and evaluate clinical phenotypes. This year’s event centers on a high-stakes community experiment: a collaborative "Phenotype Challenge" where participants will focus on a single clinical condition. The goal is to move through an end-to-end, iterative development cycle that combines human expertise with cutting-edge tools to establish a gold standard for phenotype definitions within the OMOP Common Data Model.

The primary objective of this year’s initiative is to test a systematic, AI-assisted workflow. By integrating LLMs with established OHDSI tools like KEEPER and CohortDiagnostics, the community aims to explore how reasoning models can enhance phenotype development, evaluation, and refinement. This experiment has the potential to significantly improve the accuracy and scalability of clinical research, providing a roadmap for generating high-quality evidence across diverse observational data sources worldwide.

Participation is open to all members of the OHDSI community, regardless of their level of expertise. Collaborators can get involved by voting on the target condition, submitting phenotype definitions—whether rule-based, machine learning-based, or hybrid—and participating in the iterative refinement process based on data-driven feedback. Data partners are also encouraged to run definitions locally to strengthen the generalizability of the results. Weekly Phenotype Workgroup calls and community updates will provide ongoing support and insights throughout the month of February.

Phenotype Phebruary: Details, Key Dates, How To Get Involved
My Journey: Erica Voss
What happens when you trade "counting widgets" for analyzing patient-level data? In the debut of our "My Journey" series, Erica Voss shares her transition into the OHDSI community, how large-scale data can answer critical questions that clinical trials often can’t, and what she finds so exciting about the future of real-world evidence.
Europe Symposium Agenda Announced; Showcase Submissions Due Friday, Feb. 6
Continuous Collaboration for Living Evidence Generation is the theme for the seventh OHDSI Europe Symposium, which will be held April 18-20 in Rotterdam. Registration has opened for the event, which will conclude with the main conference on the SS Rotterdam.

The tentatative agenda for the main conference is now available, and it features sessions on the OHDSI journey, Europe National Nodes, future paths for the community, and more. There will be two collaborator showcase sessions, but the deadline to join this event is rapidly approaching. All abstracts must be submitted by Friday, Feb. 6.

The links below provide all pertinent details for the event. We hope to see you in Rotterdam!  
Europe Symposium Homepage: Agenda and Information
Register for the Europe Symposium
Collaborator Showcase Submission Information

Ilse Vermeulen works at the intersection of real-world data, health system transformation, and multi-stakeholder collaboration. Originally trained as a bioengineer, she earned a PhD in Medical Sciences from the Vrije Universiteit Brussels and developed her expertise in large-scale health data ecosystems later in her career through hands-on practice and community-driven learning within the OHDSI ecosystem, under the mentorship of Prof. Liesbet M. Peeters. Her work focuses on enabling collaboration across institutions and disciplines to make health data more interoperable, trustworthy, and usable for research and decision-making.

She serves as the National Node Manager of OHDSI Belgium, where she helps connect Belgian hospitals, researchers, and partners to the broader OHDSI community in Europe and beyond. Known for her versatility and ability to navigate complexity, Ilse brings together technical understanding, coordination, and community building to support federated research and real-world evidence generation. From January 2026 onward, she joined the Medical Informatics team at Erasmus MC as a Project Manager, contributing to the coordinating centers of OHDSI Europe and DARWIN EU. Across her roles, she is driven by the belief that meaningful innovation in healthcare emerges not from silos, but from sustained collaboration across people, systems, and perspectives.

In the latest edition of the Collaborator Spotlight, Ilse discusses her career journey, her work with the Belgian National Node and the 2025 Europe Symposium, the future possibilities for European healthcare, and plenty more.

Spotlight: Ilse Vermuelen
January Publications
Van der Pol H, Kringelbach T, Martin Agudo M, Bratseth Stav G, Fagereng GL, Fiocco M, Sørum Falk R, Homer V, Haj Mohammad S, Timmer H, Verlingue L, Helland Å, Rohrberg K, Lassen U, Halford S, Jalkanen K, Juslin T, Krebs MG, Oliveira J, Baltruskeviciene E, Ojamaa K, Taskén K, Gelderblom H. Procedures of data merging in precision cancer medicine: the PRIME-ROSE project. Acta Oncol. 2026 Jan 6;65:1-8. doi: 10.2340/1651-226X.2026.44889. PMID: 41496458; PMCID: PMC12789942.

Gong G, Liu J, Pandya S, Taborda C, Wiesendanger N, Price N, Byron W, Coppi A, Young P, Wiess C, Dunning H, Barganier C, Brodeur R, Fischbach N, LoRusso P, Pusztai L, Kim SY, Rozenblit M, Cecchini M, Mongiu A, Mendez L, Kaftan E, Torre C Jr, Krumholz H, Krop I, Schulz W, Lustberg M, Kunz PL. Clinical Trial Patient Matching: A Real-Time, Common Data Model and Artificial Intelligence-Driven System for Semiautomated Patient Prescreening in Cancer Clinical Trials. JCO Clin Cancer Inform. 2026 Jan;10:e2500262. doi: 10.1200/CCI-25-00262. Epub 2026 Jan 9. PMID: 41512229.

Liu J, Pandya S, Coppi A, Young HP, Krumholz HM, Schulz WL, Gong G. Assessment of the integrity of real-time electronic health record data used in clinical research. PLoS One. 2026 Jan 9;21(1):e0340287. doi: 10.1371/journal.pone.0340287. PMID: 41511976; PMCID: PMC12788664.

Hripcsak G, Suchard MA, Schuemie MJ, Ryan PB. Trust in Observational Research. J Am Coll Cardiol. 2026 Jan 10:S0735-1097(25)10278-7. doi: 10.1016/j.jacc.2025.11.023. Epub ahead of print. PMID: 41563171.

Vercammen C, Heinrich A, Lesimple C, Paglialonga A, Wasmann JA, Buhl M. Data standards in audiology: a mixed-methods exploration of community perspectives and implementation considerations. Int J Audiol. 2026 Jan 28:1-17. doi: 10.1080/14992027.2026.2619921. Epub ahead of print. PMID: 41604223.
January Presentations
Jan. 13 - Where Can OHDSI Go Together in 2026?
Paths Forward for Our Global Community (Ryan)

Jan. 27 - Brainstorms For Global Collaboration
Innovation Brainstorm (Ryan)
Education Brainstorm (Nagy)
LinkedIn
Twitter
YouTube
Website
Instagram
GitHub
Email
Copyright © 2026 Observational Health Data Sciences and Informatics (OHDSI), All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp